Notify me when Auctus Fund Management LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| BRTX | BioRestorative Therapies, Inc. | Common Stock, $0.0001 par value | 9.9% | $1,084,034 | +$134,602 | 895,896 | +14% | Auctus Fund, LLC | 31 Dec 2025 |
| GTHP | GUIDED THERAPEUTICS INC | Common Stock, par value $0.001 per share | 9.9% | $638,535 | 5,804,865 | Auctus Fund Management LLC | 30 Sep 2024 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|